CD8A and neoplasm: Furthermore, TGR5 (also known as GPBAR1) was found on infiltrated TAMs, where it affects anti-tumor immunity by contributing to TAM-mediated blockage of CD8+ T cell functions and overall survival in NSCLC patients [527].